Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001225106 | SCV001397342 | uncertain significance | not provided | 2022-09-27 | criteria provided, single submitter | clinical testing | This sequence change replaces serine, which is neutral and polar, with phenylalanine, which is neutral and non-polar, at codon 2650 of the EYS protein (p.Ser2650Phe). This variant is present in population databases (rs374714909, gnomAD 0.08%). This missense change has been observed in individuals with retinal dystrophy (PMID: 24938718, 25356976). ClinVar contains an entry for this variant (Variation ID: 636169). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on EYS protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV001830681 | SCV002801522 | uncertain significance | Retinitis pigmentosa 25 | 2022-04-18 | criteria provided, single submitter | clinical testing | |
Dept Of Ophthalmology, |
RCV000787834 | SCV004707419 | pathogenic | Retinal dystrophy | 2023-10-01 | criteria provided, single submitter | research | |
Juno Genomics, |
RCV001830681 | SCV005418036 | uncertain significance | Retinitis pigmentosa 25 | criteria provided, single submitter | clinical testing | PM2_Supporting+PM3_Supporting+PP4 | |
Department of Clinical Genetics, |
RCV000787834 | SCV000926848 | likely pathogenic | Retinal dystrophy | 2018-04-01 | no assertion criteria provided | research | |
Natera, |
RCV001830681 | SCV002083503 | uncertain significance | Retinitis pigmentosa 25 | 2020-12-27 | no assertion criteria provided | clinical testing |